Alterola Biotech, Inc. (ABTI)
OTCMKTS · Delayed Price · Currency is USD
0.2000
+0.1998 (99,900.00%)
Oct 31, 2025, 3:00 PM EST
Alterola Biotech Company Description
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.
It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability.
Alterola Biotech, Inc. is based in Birkenhead, the United Kingdom.
Alterola Biotech, Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1 |
| CEO | David Hitchcock |
Contact Details
Address: 47 Hamilton Square Birkenhead, Nevada CH41 5AR United Kingdom | |
| Phone | 44 1516 019 477 |
| Website | alterola-abti.com |
Stock Details
| Ticker Symbol | ABTI |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US02152V1035 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| David John Hitchcock O.B.E. | Chief Executive Officer |
| Nathan Thompson | Chief Financial Officer and Secretary |
| Colin G. Stott B.Sc. | Chief Operating Officer and Director |
| Dominic Schiller | IP Counsel, Chief IP Officer and Director |